Leukemia

Approvals of orphan drugs will continue to rise in 2015, says Frost & Sullivan

Novel orphan drug boom in 2015, predict experts

By Anthony King

The pharma industry reached a high water mark in 2014 with a record number of new molecular entities approved by the US Food and Drug Administration, especially orphan drugs.

Troubled CMO Ben Venue extends manufacturing shutdown

Troubled CMO Ben Venue extends manufacturing shutdown

By Gareth Macdonald

Ben Venue Laboratories will not restart manufacturing at its plant in Bedford, Ohio until later this quarter – at the earliest - after extending the voluntary suspension it implemented in November.